Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-08-19
    E.g., 2018-08-19

Archive Search

2 results
11:12 AM, Dec 15, 2016  |  BC Innovations | Product R&D

p53 and Ras: Back from the dead

engineered T cell receptor (TCR) that binds mutant KRAS Preclinical siRNA Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA); Kyowa Hakko Kirin
year to use chemical modifications on antibodies to enable cell entry. Dicerna Pharmaceuticals Inc. and Kyowa Hakko Kirin
New Brunswick, N.J. Kite Pharma Inc. (NASDAQ:KITE), Los Angeles, Calif. Kura Oncology Inc., Glendale, Calif. Kyowa Hakko Kirin
12:00 AM, Nov 19, 2015  |  BC Innovations | Product R&D

A solid move

deals this year. First, it licensed a mammalian cell line from BioWa Inc. , a Kyowa Hakko Kirin
Sweden Cellerant Therapeutics Inc., San Carlos, Calif. Glycotope GmbH, Berlin, Germany Innovagen AB, Lund, Sweden Kyowa Hakko Kirin